HALO 2022 Q3
Halozyme Therapeutics (HALO) reports qtrly profits (EPS):
Reported: $0.53 vs. $0.62 = -15%
Estimates: $0.50 vs. $0.62 = -19%
Beat the street by $0.03
Revenue: +12%
Loading view.
HALO 2022 Q4
Halozyme Therapeutics (HALO) reports qtrly profits (EPS):
Reported: $0.74 vs. $0.51 = +45%
Estimates: $0.52 vs. $0.51 = +2%
Beat the street by $0.22
Revenue: +80%
HALO 2023 Q1
Halozyme Therapeutics (HALO) reports qtrly profits (EPS) and revenues:
Reported: $0.48 vs. $0.42 = +14%
Estimates: $0.45 vs. $0.42 = +7%
Beat the street by $0.03
Revenue: +78%
Revenue Est: +86%
HALO 2023 Q2
Halozyme Therapeutics (HALO) is expected to report qtrly profits (EPS) and revenues:
Profits Estimates: $0.50 vs. $0.47 = +6%
Revenue Est: +54%